https://doi.org/10.1016/j.celrep.2012.06.017
S
Shensi Shen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
116
Papers
7.8K
Citations
34
h-index
48
i10-index
Shensi Shen is an academic researcher from Sichuan University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Autophagy in Disease and Therapy & Immunotherapy and Immune Responses. The author has an h-index of 34, co-authored 99 publications.
ORCID: 0000-0002-5087-8220Papers by this author
worksPrognostic Impact of Vitamin B6 Metabolism in Lung Cancer
2012 · Cell Reports · 133 citations
Cancer drug-tolerant persister cells: from biological questions to clinical opportunities
2024 · Nature reviews. Cancer · 117 citations
https://doi.org/10.1038/s41568-024-00737-z
Wedelolactone, a Naturally Occurring Coumestan, Enhances Interferon-γ Signaling through Inhibiting STAT1 Protein Dephosphorylation
2013 · Journal of Biological Chemistry · 39 citations
https://doi.org/10.1074/jbc.m112.442970
Drug-tolerant persister cells in cancer: bridging the gaps between bench and bedside
2025 · Nature Communications · 7 citations
https://doi.org/10.1038/s41467-025-66376-6
Metabolism and mRNA translation: a nexus of cancer plasticity
2024 · Trends in Cell Biology · 6 citations
https://doi.org/10.1016/j.tcb.2024.10.009
In situ detection of the eIF4F translation initiation complex in mammalian cells and tissues
2021 · STAR Protocols · 3 citations
https://doi.org/10.1016/j.xpro.2021.100621
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat